Blood Cancer Awareness Month

September is Blood Cancer Awareness Month, a vital month to raise the profile of blood cancers like leukaemia, lymphoma and myeloma.

Every year, over 20,000 Australians are diagnosed with a blood cancer, and 140,000 are living with blood cancer and receiving treatment. Blood cancers collectively make up the fourth biggest group of diagnosed cancers in Australia annually, and 6,000 people die each year from blood cancer.

While these statistics are sobering, there is hope for people with blood cancer. Research is vital to improve outcomes for patients with blood cancer, and clinical trials are the crucial link between a discovery made in the research lab and a new treatment reaching patients.

ALLG is the only not-for-profit, collaborative, blood cancer clinical trial research group in Australasia. Our organisation is made up of over 1,400 blood cancer specialists, researchers and clinical trial professionals, all dedicated to creating better treatments and better lives for patients with blood cancer.

Our mission is to create better treatments and better lives for patients with blood cancer. We will achieve this through designing and conducting our leading-edge blood cancer clinical trials and research across Australia and New Zealand.

But we can’t achieve this alone – we need you to join our team.

 

How you can help

By supporting ALLG this Blood Cancer Awareness Month, you are an essential part of the team that is fighting to find a cure for blood cancer through ground-breaking clinical research.

Please join the ALLG team and donate or fundraise this September. Why not host a morning tea at your work or with family and friends, or a quiz and pizza night at home. You could join a challenge running or cycling event and raise funds. Or, simply make a donation to help ALLG progress our world-leading clinical trial research.

Every dollar goes directly to our clinical trial research to accelerate better blood cancer treatments for patients. For more fundraising ideas or to donate, visit www.allg.org.au/support-us

 

ALLG Clinical Trials

ALLG has had over five decades of impact in blood cancer clinical trials. Our research has shifted the dial for patients and changed the way blood cancers are treated globally.

ALLG’s doctor-led research network, multi-partner approach and independence ensures we have the ability to bring the best of the best forward in our clinical trials – the best science, the best treatments and the best opportunities for patients with blood cancers.

Our members conduct clinical trials into the full spectrum of blood cancers, including acute and chronic leukaemias, Non-Hodgkin and Hodgkin lymphomas, Multiple Myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs). For more information on ALLG’s current clinical trials, visit https://www.allg.org.au/clinical-trials-research/current-clinical-trials/